Phibro Animal Health - PAHC Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" PAHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PAHC, but not buy additional shares or sell existing shares.
View PAHC analyst ratings or view top-rated stocks.

2 Wall Street research analysts have issued 1-year target prices for Phibro Animal Health's stock. Their PAHC share price forecasts range from $22.00 to $23.00. On average, they anticipate the company's share price to reach $22.50 in the next twelve months. This suggests a possible upside of 18.6% from the stock's current price.
View analysts price targets for PAHC or view top-rated stocks among Wall Street analysts.

Phibro Animal Health's stock was trading at $20.42 at the beginning of the year. Since then, PAHC stock has decreased by 7.1% and is now trading at $18.97.
View the best growth stocks for 2022 here.

Phibro Animal Health is scheduled to release its next quarterly earnings announcement on Wednesday, August 24th 2022.
View our PAHC earnings forecast.

Phibro Animal Health will be holding an earnings conference call on Thursday, August 25th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Phibro Animal Health Co. (NASDAQ:PAHC) announced its earnings results on Tuesday, November, 2nd. The company reported $0.25 earnings per share for the quarter, missing the consensus estimate of $0.29 by $0.04. The firm had revenue of $214.70 million for the quarter. Phibro Animal Health had a trailing twelve-month return on equity of 21.06% and a net margin of 6.48%. During the same period in the previous year, the company earned $0.27 earnings per share.

Phibro Animal Health announced a quarterly dividend on Monday, July 25th. Stockholders of record on Wednesday, September 7th will be given a dividend of $0.12 per share on Wednesday, September 28th. This represents a $0.48 dividend on an annualized basis and a yield of 2.53%. The ex-dividend date of this dividend is Tuesday, September 6th.
Read our dividend analysis for PAHC.

Phibro Animal Health (NASDAQ:PAHC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 2.51%. The dividend payout ratio is 33.10%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, PAHC will have a dividend payout ratio of 33.33% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for PAHC.

Phibro Animal Health issued an update on its FY 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share (EPS) guidance of $1.30-$1.39 for the period, compared to the consensus estimate of $1.36. The company issued revenue guidance of $930.00 million-$950.00 million, compared to the consensus revenue estimate of $907.54 million.

4 employees have rated Phibro Animal Health Chief Executive Officer Jack Bendheim on Glassdoor.com. Jack Bendheim has an approval rating of 100% among the company's employees. This puts Jack Bendheim in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Intercept Pharmaceuticals (ICPT), VIVUS (VVUS), Zoetis (ZTS), Banco Bradesco (BBD) and Booking (BKNG).

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

Phibro Animal Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include Pzena Investment Management LLC (4.78%), Victory Capital Management Inc. (1.11%), Smith Graham & Co. Investment Advisors LP (0.80%), Chartwell Investment Partners LLC (0.52%), Russell Investments Group Ltd. (0.44%) and Confluence Investment Management LLC (0.21%). Insiders that own company stock include E Thomas Corcoran and Larry Lee Miller.
View institutional ownership trends.

Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PAHC stock can currently be purchased for approximately $18.97.

Phibro Animal Health (NASDAQ:PAHC) has a market capitalization of $768.36 million and generates $833.40 million in revenue each year. The company earns $54.38 million in net income (profit) each year or $1.45 on an earnings per share basis.

Phibro Animal Health employs 1,725 workers across the globe.

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The official website for the company is www.pahc.com. The company can be reached via phone at (201) 329-7300, via email at investor.relations@pahc.com, or via fax at 201-329-7399.